相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A clioquinol-containing Pluronic(R) F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model
Grasiele S. V. Tavares et al.
PARASITE (2020)
Visceral Leishmaniasis Recent Advances in Diagnostics and Treatment Regimens
Johan van Griensven et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Current and emerging medications for the treatment of leishmaniasis
Jaya Chakravarty et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems
Victoria Wagner et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Oral pentamidine-loaded poly(d,l-lactic-co-glycolic) acid nanoparticles: an alternative approach for leishmaniasis treatment
Isabela Viol Valle et al.
NANOTECHNOLOGY (2019)
A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis
Jessica K. T. Sousa et al.
PARASITOLOGY INTERNATIONAL (2019)
Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy
Alti Dayakar et al.
FRONTIERS IN IMMUNOLOGY (2019)
Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar
Shyam Sundar et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic (R) F127-based polymeric micelle system against Leishmania amazonensis infection
Debora V. C. Mendonca et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Cardiotonic steroids as potential Na+/K+-ATPase inhibitors - a computational study
Chirag N. Patel et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2019)
Chemotherapeutics of visceral leishmaniasis: present and future developments
Shyam Sundar et al.
PARASITOLOGY (2018)
Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L-amazonensis species
Debora Vasconcelos Costa Mendonca et al.
PARASITOLOGY RESEARCH (2018)
Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species
Grasiele de Sousa Vieira Tavares et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Elderly patients with suspected chronic digoxin toxicity: A comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab
Hooman Arbabian et al.
EMERGENCY MEDICINE AUSTRALASIA (2018)
Leishmaniasis treatment: update of possibilities for drug repurposing
Valter Viana Andrade-Neto et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Clinical Use of Digitalis: A State of the Art Review
Thomas F. Whayne
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
A real-time PCR assay for quantification of parasite burden in murine models of leishmaniasis
Alejandro L. Antonia et al.
PEERJ (2018)
Eugenol derived immunomodulatory molecules against visceral leishmaniasis
Mamilla R. Charan Raja et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Molecular mechanisms of anti-oxidant and anti-aging effects induced by convallatoxin in Caenorhabditis elegans
Jia Xu et al.
FREE RADICAL RESEARCH (2017)
Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis
Pankaj K. Singh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Nanostructured delivery systems with improved leishmanicidal activity: a critical review
Natascia Bruni et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
Muzamil Y. Want et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Development and evaluation of zinc phthalocyanine nanoemulsions for use in photodynamic therapy for Leishmania spp.
Luciana Betzler de Oliveira de Siqueira et al.
NANOTECHNOLOGY (2017)
Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
Saumya Srivastava et al.
PARASITES & VECTORS (2017)
Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis
Fauzia Jamal et al.
PLOS ONE (2017)
Digoxin use in atrial fibrillation
Murat Biteker et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2017)
Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system
Mariana Costa Duarte et al.
PARASITOLOGY INTERNATIONAL (2016)
Successful Treatment of Human Visceral Leishmaniasis Restores Antigen-Specific IFN-γ, but not IL-10 Production
Emebet Adem et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Apocynaceae species with antiproliferative and/or antiplasmodial properties: a review of ten genera
Eric Wei Chiang Chan et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2016)
Investigational drugs for visceral leishmaniasis
Shyam Sundar et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Topical Resiquimod Protects against Visceral Infection with Leishmania infantum chagasi in Mice
Noah Craft et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
Suman Rijal et al.
CLINICAL INFECTIOUS DISEASES (2013)
Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
M. Slingerland et al.
INVESTIGATIONAL NEW DRUGS (2013)
Cardiotonic Steroids-Mediated Na+/K+-ATPase Targeting Could Circumvent Various Chemoresistance Pathways
Tatjana Mijatovic et al.
PLANTA MEDICA (2013)
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis
Abeer H. A. Mohamed Ahmed et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Digitonin synergistically enhances the cytotoxicity of plant secondary metabolites in cancer cells
Safaa Yehia Eid et al.
PHYTOMEDICINE (2012)
Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
Om Prakash Singh et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Biotransformation of digitoxigenin by Fusarium ciliatum
RM Pádua et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2005)
The immunopathology of experimental visceral leishmaniasis
PM Kaye et al.
IMMUNOLOGICAL REVIEWS (2004)
Digoxin in heart failure and cardiac arrhythmias
TJ Campbell et al.
MEDICAL JOURNAL OF AUSTRALIA (2003)
Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection
EAF Coelho et al.
INFECTION AND IMMUNITY (2003)
分享论文
